Business Wire

Consumer Tech Growth to Reset in 2026 as Demand Shifts to Europe and MEA

4.1.2026 13:00:00 CET | Business Wire | Press Release

Share

NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today released its 2026 Consumer Tech & Durable Goods (T&D) market outlook. In collaboration with the Consumer Technology Association (CTA), NIQ expects T&D global sales to level off in 2026 after a strong 2025. The sector is set to finish 2025 at roughly $1.3 trillion USD, up 3% from 2024, while 2026 overall sales value is projected to hold steady at an estimated -0.4% year over year (YoY).

While the global picture looks flat, the real story lies in the differences in regional and sector performance. Consumers overall remain careful with their spending and are prioritizing value for money—with a focus on products that offer enhanced performance, convenience, energy-saving, and/or durability. Brands and retailers that align pricing, innovation, and experience to region- and category-specific demand will win share of wallet.

“In 2025, global Consumer Tech & Durable goods purchases grew by a solid 3%. Growth is expected to slow in 2026, but most regions should remain stable or see modest gains. The exception is China, where elevated baselines from recent trade-in policies will weigh on performance,” said Julian Baldwin, President of Tech & Durables at NIQ. “Looking ahead, the next phase of growth will rely less on broad market recovery and more on how effectively brands tailor innovation, pricing, and features to meet local consumer expectations.”

Key insights and emerging trends for 2026 include:

  • Market Outlook: Consumer Tech & Durable Goods sales are projected to reach $1.3T in 2025 (+3% vs. 2024), before softening slightly in 2026 (-0.4% YoY). Growth will be led by Eastern Europe (+5%), Western Europe (+3%), MEA (+3%), and Latin America (+2%), while North America holds steady and Asia-Pacific declines (-3%, driven by China at -5%).
  • Sector Trends: Small Domestic Appliances (SDA) will grow, IT & Office will see modest gains, Major Domestic Appliances remain stable, and Telecom and Consumer Electronics experience slight declines.
  • Consumer & Product Dynamics: Value-for-money remains a top priority, meaning that product benefits must be both highly relevant and visible to shoppers. Replacement cycles for PCs and smartphones, combined with premiumization trends—AI-native PCs, Mini LED/OLED TVs, built-in appliances, and smart home appliances—will help drive demand. TVs get a boost from the 2026 World Cup, while open-ear headsets sustain momentum, and AI-enabled features with clear use cases offer premiumization potential.
  • Strategic Considerations: Focus growth strategies on high-potential markets by volume and value. Monitor policy and trade factors, including evolving U.S. tariffs, China’s trade-in programs, and expanding competition from Chinese brands entering new markets, as affordability and accessibility drive AI adoption globally.

“Despite easing inflation and resilient demand in many regions, risks from tariffs and supply chain disruptions persist,” said Steve Koenig, Vice President of Research, Consumer Technology Association. “Consumers remain value-driven but are prepared to spend where they see compelling product features. Built-in Artificial Intelligence continues to present strong opportunity as a product differentiator, but adoption will depend on clear use cases that illustrate direct benefits and ROI.”

The outlook comes as NIQ leaders—including Julie Kenar, SVP Automotive Business, and Sherry Frey, VP Total Wellness—prepare to share insights at CES 2026, taking place January 6-9 in Las Vegas. For deeper insights, explore NIQ’s 2026 market estimate for Consumer Tech & Durable Goods.

About NIQ
NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete understanding of consumer buying behavior and revealing new pathways to growth. Our global reach spans over 90 countries covering approximately 85% of the world’s population and more than $7.2 trillion in global consumer spend. With a holistic retail read and the most comprehensive consumer insights—delivered with advanced analytics through state-of-the-art platforms—NIQ delivers the Full View™.

For more information, please visit: www.niq.com

About Consumer Technology Association
As North America’s largest technology trade association, CTA®is the tech sector. Our members are the world’s leading innovators — from startups to global brands — helping support more than 18 million American jobs. CTA owns and produces CES® — the most influential tech event in the world. Find us at CTA.tech. Follow us @CTAtech.

Forward-Looking Statements Disclaimer
This Consumer Tech Outlook release may contain forward-looking statements regarding anticipated consumer behaviors, market trends, and industry developments. These statements reflect current expectations and projections based on available data, historical patterns, and various assumptions. Words such as “expects,” “will,” “anticipates,” “projects,” “believes,” “forecasts,” “estimate,” and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future outcomes and are subject to inherent uncertainties, including changes in consumer preferences, economic conditions, technological advancements, and competitive dynamics. Actual results may differ materially from those expressed or implied in these statements. While we strive to base our insights on reliable data and sound methodologies, we undertake no obligation to update any forward-looking statements to reflect future events or circumstances, except to the extent required by applicable law.

Note to Editors
NIQ’s Consumer Tech & Durable Goods (T&D) experts, working with the Consumer Technology Association, model their 2026 Consumer Tech market estimate using long-term and current trend data. Our market growth estimate assumes that China continues a level of financial support for their domestic market in 2026, but not to the extent seen in 2025, model their 2026 Consumer Tech market estimate using long-term and current trend data. Our market growth estimate assumes that China continues a level of financial support for their domestic market in 2026, but not to the extent seen in 2025.

Disclaimer
All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.

© 2026 Nielsen Consumer LLC. All Rights Reserved.

NIQ-GENERAL

View source version on businesswire.com: https://www.businesswire.com/news/home/20260104140033/en/

Contacts

Media Contact: media.relations@niq.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press Release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press Release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press Release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye